Patient-reported Outcome and Patient-reported Experience After Status Epilepticus
NCT06100978
Behavior, Burden
Angoulême, France
View Trial DetailsNCT Number: NCT05491590
Status epilepticus (SE) is a common life-threatening neurological emergency in which prolonged or multiple closely spaced seizures can result in long-term impairments. SE remains associated with considerable mortality and morbidity, with little progress over the last three decades. The proportion of patients who die in the hospital is about 20% overall and 40% in patients with refractory SE. Morbidity is more difficult to evaluate, as adverse effects of SE are often difficult to differentiate from those attributed to the cause of SE. Our experience suggests that nearly 50% of patients may experience long-term functional impairments.
The precise description of the consequences of these functional impairments and their impact on quality of life after SE requiring intensive care management has been little studied.
Indeed, if cognitive, physical and mental impairments are now identified in the populations of patients who required intensive care under the term post-resuscitation syndrome (PICS), neuronal lesions consecutive to the SE itself or to its cause could be responsible for these different functional alterations. Thus, the following have been described: (i) cognitive disorders in the areas of attention, executive functions and verbal fluency, visual and working memory disorders, but also spatio-temporal disorders; (ii) physical disorders such as the so-called post-resuscitation polyneuromyopathy; and (iii) mental disorders such as anxiety disorders, depressive states or those related to post-traumatic stress.
Assessment and characterization of patient-reported outcomes is essential to complement the holistic assessment of clinically relevant outcomes from the patient's perspective. Here, we propose the development of a cross-sectional collection of PROs of the different constituents of PICs and HR-QOLs, and associated with functional patient outcomes, in those who required ICU management for status epilepticus.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
CHVersailles, Le Chesnay, Yvelines, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: one day
36-Item Short Form Survey (SF-36) (HRQoL)-Ranging score[0-100], a high score indicate better health status.
Time frame: one day
Time frame: one day
-QOLIE 31 measure of spécific QoL of epileptics patients, 30 items are organized into seven subscales:Ranging score[0-100], a high score indicate better health status.
Time frame: one day
Time frame: one day
cf outcomes 2
Time frame: one day
Time frame: one day
A return to work or school will be interpreted by the structured GOS interview.
Time frame: one day
The Social Support Questionnaire- Short Form-SSQ6 / 6 item measure of social support, with scores ranging from 0 (no social support) to 6 (very high social) and 1 (very dissatisfied) to 6 (very satisfied) for the area of satisfaction in each item or area. From these scores in the 6 domains, an average score was calculated for the number of supports available -Ranging score[0-54] and for satisfaction.Ranging score[0-36]
Time frame: one day
Versailles Hospital
Other
Patient-reported Outcomes in Status Epilepticus Requiring Intensive Care Unit Management
Acronym: POSEIDON
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06100978
Behavior, Burden
Angoulême, France
View Trial DetailsNCT03178045
Patient Reported Outcomes
New York, United States
View Trial DetailsNCT04236934
Diaphragm Movement, Dyspnea
Næstved, Region Sjælland, Denmark
View Trial DetailsNCT04533867
Antiemetics, Nausea
Istanbul, Turkey (Türkiye)
View Trial Details